Atlantic BioCorp is a Canadian biotech platform building the nation’s first
industrial-scale supply of high-quality marine biomaterials. Focused on chitin, chitosan and advanced derivatives — transforming marine biomass from fisheries bycatch into high performance ingredients for today’s markets and tomorrow’s technologies.
ABC Inc, focuses on scale production, R&D partnership and custom offerings for:
Life sciences - medical devices - pharmaceuticals - bone and tissue repair - natural health products - skincare - wound care
Industrial - rare & precious mineral recovery - water & site treatments - packaging strength - hydro carbon free plastics
Agricultural - seed coatings - natural pest control - microbial defense - growth promotion - soil conditioning
Textiles - anti microbial & bacterial cloth treatments - natural athletic & high demand solutions - nanocrystal thread additives
Defense & Emergency Response - hemostatic applications, advanced energetics’ - R&D for forward deployed smart materials
and this is just the beginning…
By leveraging our proprietary M.C.E. process ABC Preserves the best quality “Alpha Structure” chitin, chitosan and derivatives Platform-first and future-ready, Atlantic BioCorp scales biopolymer production to meet today’s demands and tomorrow’s material challenges. Our core portfolio—chitin, chitosan and advanced derivatives is reliable, auditable and built on a Canadian circular-economy model.
Regulatory-Compliant || Fully Traceable Supply || Quality Assurance || Collaborative Partnerships || Cutting Edge R&D
Redefining the Values of a Sustainable, Sovereign Model for Canada’s Biotech Industry
Founders and Vision
Atlantic Bio Corp was founded by a team of trailblazers who saw possibility where others saw waste. With deep roots in biochemistry, marine science, and sustainable innovation, our founders united around a bold vision: to transform Canada’s shrimp shell byproduct into the world’s most trusted source of medical-grade chitosan. Their leadership blends scientific rigor with entrepreneurial spirit, anchored in a commitment to community, environmental stewardship, and global impact. From the labs of Saint Anthony to international biotech stages, their legacy is one of courage, collaboration, and Canadian excellence.
-
Founder & CEO
Dante Enewold is the founder and CEO of Atlantic BioCorp, a Newfoundland-based startup transforming crab waste into high-grade chitosan for biomedical and industrial use.
Background and Education
Academic foundation: Dante holds a Bachelor of Commerce (Development Economics), a Bachelor of Arts in Philosophy and Religious Studies, and a Master of Arts in Philosophy from Memorial University of Newfoundland.
Research experience:
He contributed to academic studies on business strategy and economic phenomena, including analyses of “zombie companies” and blitzkrieg strategies in business.
Entrepreneurial Vision
• Atlantic BioCorp origin: Inspired by his time as a procurement officer in the fishing industry, Dante saw firsthand the volume of crab shell waste and envisioned a sustainable solution.
• Innovation focus: Atlantic BioCorp specializes in upcycling fisheries byproducts into biomedical-grade chitosan, a versatile biopolymer used in pharmaceuticals, water treatment, cosmetics, and food stabilization.
Achievements and Milestones
• Mel Woodward Cup winner (2024): Dante won the top prize of $25,000 for Atlantic BioCorp’s pitch, which helped fund the development of a production facility.
• Rapid progress: Within a year of founding the company, he secured a supplier, completed a fundraising round, and began engaging with customers in British Columbia.
Career Highlights
• Royal Greenland: Gained hands-on logistics and procurement experience in the fisheries sector.
• Paradigm Hyperloop: As Senior Manager of Project Finance, he helped build one of North America’s fastest student-designed hyperloop prototypes.
Teaching and research:
Served as a teaching assistant and research analyst in business strategy and international business at Memorial University.
Dante’s blend of philosophical insight, business acumen, and sustainability-driven innovation positions him as a rising leader in Canada’s biotech and cleantech sectors.
-
Founder & Chief Operating Officer
Overview
Shane Yamamoto is a Founder and the Chief Operating Officer of Atlantic BioCorp. He leads development and scale-up of the company’s marine bioproduct platform and its flagship industrial facility in St. Anthony, turning validated chemistry into audit-ready, commercially viable products for regulated and advanced markets.
Applied Systems Delivery
An inventive, applied problem-solver, Shane designs large technical systems and stages multi-site rollouts with minute-level logistics, live communications and hands-on commissioning. He converts process designs into dependable, repeatable operations by coordinating trades, contractors and operators and by building resilient operational architectures that prioritize uptime, traceability and practical performance.
Governance & Commercial Strategy
Shane bridges corporate governance and frontline delivery: authoring governance-grade SOPs, establishing IP capture and audit-ready documentation, and translating those systems into pragmatic work packages. His international commercial experience across Asia, Europe and the United States informs supply-chain design, procurement, import/export and disciplined scale plans. He pairs technical roadmaps with market strategy to create premium product specifications, defensible pricing and measurable go-to-market funnels that move pilots into contracted, revenue-producing operations.
Community, Roots & Ambition
Shane’s work is personal. His grandfather — a Japanese immigrant and commercial fisherman on Canada’s Pacific coast — taught him determination and practical resilience through the boom-and-bust cycles of the fishery. That upbringing drives Shane’s commitment to zero-waste, locally beneficial industrial platforms that deliver cleaner shores, higher-value byproducts and stronger coastal economies. He splits his time between Kelowna, B.C., and St. John’s / St. Anthony, Newfoundland, and is focused on implementing national industrial infrastructure and applied R&D platforms that scale regional benefit into sovereign Canadian capability.
ABC’s Mission Statement
At Atlantic Bio Corp, we believe science and sustainability must work hand in hand. Through our Green Horizon initiative, we upcycle fisheries byproducts into high-value biopolymers, champion clean oceans, and reduce landfill waste with biodegradable solutions. Our mission is to transform industry practices while protecting the planet that sustains us
ABC’s Vision Statement
Atlantic Bio Corp envisions a future where every industry is powered by sustainable biopolymers, oceans are free from waste, and natural resources are regenerated through innovation. By leading the global transition from petroleum-based materials to circular, eco-smart solutions, we aim to redefine biotechnology as a force for environmental restoration and industrial progress
